Physical activity and hospitalization for exacerbation of COPD

被引:485
作者
Pitta, F
Troosters, T
Probst, VS
Spruit, MA
Decramer, M
Gosselink, R
机构
[1] Katholieke Univ Leuven Hosp, Resp Rehabil & Resp Div, Louvain, Belgium
[2] Katholieke Univ Leuven, Dept Rehabil Sci, Fac Kinesiol & Rehabil Sci, Louvain, Belgium
[3] Univ Estadual Londrina, Dept Physiotherapy, Londrina, Brazil
关键词
accelerometer; acute exacerbation; COPD; hospitalization; physical activity;
D O I
10.1378/chest.129.3.536
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Background: Acute exacerbations (AEs) have a negative impact on various aspects of the progression of COPD, but objective and detailed data on the impact of hospitalizations for an AE on physical activity are not available. Objective and measurements: We aimed to investigate physical activity using an activity monitor (DynaPort; McRoberts; the Hague, the Netherlands), pulmonary function, muscle force, 6-min walking distance, and arterial blood gas levels in 17 patients (mean age, 69 +/- 9 years [+/- SD]; body mass index, 24 +/- 5 kg/m(2)) at the beginning and end of a hospitalization period for an AE and I month after discharge. Results: Time spent on weight-bearing activities (walking and standing) was markedly low both at day 2 and day 7 of hospitalization (median, 7%; interquartile range [IQR], 3 to 18% of the time during the day; and median, 9%; IQR, 7 to 21%, respectively) and I month after discharge (median, 19% [IQR, 10 to 34%]; Friedman test, p = 0.13). Time spent on weight-bearing activities was positively correlated to quadiriceps force at the end of the hospitalization period (r = 0.47; p = 0.048). Patients with hospitalization for an AE in the previous year had an even lower activity level when compared to those without a recent hospitalization. In addition, patients with a lower activity level at 1 month after discharge were more likely to be readmitted in the following year. Conclusions: Patients with COPD are markedly inactive during and after hospitalization for an AE. Efforts to enhance physical activity should be among the aims of the disease management during and following the AE periods.
引用
收藏
页码:536 / 544
页数:9
相关论文
共 39 条
[1]  
Akima H, 1997, J Gravit Physiol, V4, pS15
[2]   Bed rest: a potentially harmful treatment needing more careful evaluation [J].
Allen, C ;
Glasziou, P ;
Del Mar, C .
LANCET, 1999, 354 (9186) :1229-1233
[3]   ANTIBIOTIC-THERAPY IN EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY-DISEASE [J].
ANTHONISEN, NR ;
MANFREDA, J ;
WARREN, CPW ;
HERSHFIELD, ES ;
HARDING, GKM ;
NELSON, NA .
ANNALS OF INTERNAL MEDICINE, 1987, 106 (02) :196-204
[4]   The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease [J].
Celli, BR ;
Cote, CG ;
Marin, JM ;
Casanova, C ;
de Oca, MM ;
Mendez, RA ;
Pinto Plata, V ;
Cabral, HJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (10) :1005-1012
[5]   Disturbances in leptin metabolism are related to energy imbalance during acute exacerbations of chronic obstructive pulmonary disease [J].
Creutzberg, EC ;
Wouters, EFM ;
Vanderhoven-Augustin, IML ;
Dentener, MA ;
Schols, AMWJ .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2000, 162 (04) :1239-1245
[6]   CORTICOSTEROIDS CONTRIBUTE TO MUSCLE WEAKNESS IN CHRONIC AIR-FLOW OBSTRUCTION [J].
DECRAMER, M ;
LACQUET, LM ;
FAGARD, R ;
ROGIERS, P .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1994, 150 (01) :11-16
[7]   Systemic anti-inflammatory mediators in COPD: increase in soluble interleukin 1 receptor II during treatment of exacerbations [J].
Dentener, MA ;
Creutzberg, EC ;
Schols, AMWJ ;
Mantovani, A ;
van't Veer, C ;
Buurman, WA ;
Wouters, EFM .
THORAX, 2001, 56 (09) :721-726
[8]   Exacerbations and time spent outdoors in chronic obstructive pulmonary disease [J].
Donaldson, GC ;
Wilkinson, TMA ;
Hurst, JR ;
Perera, WR ;
Wedzicha, JA .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2005, 171 (05) :446-452
[9]   Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease [J].
Donaldson, GC ;
Seemungal, TAR ;
Bhowmik, A ;
Wedzicha, JA .
THORAX, 2002, 57 (10) :847-852
[10]   Global strategy for the diagnosis, management and prevention of COPD: 2003 [J].
Fabbri, LM ;
Hurd, SS .
EUROPEAN RESPIRATORY JOURNAL, 2003, 22 (01) :1-2